You are here: Industry Insights > head

News List

ASTRO: NSAIDs May Offer Benefit to Head & Neck Cancer Patients drugs
September 24, 2019
Nonsteroidal anti-inflammatory drugs (NSAIDs) are correlated with better overall survival in patients with head and neck squamous cell carcinoma (HNSCC) ...
Delaying Treatment Worsens Head, Neck Cancer Outcomes drugs
September 17, 2019
Delaying time to treatment initiation (TTI) beyond 60 days is associated with decreased overall survival and increased head and neck cancer recurrence
Mild Head Injury Can Impair Your Sense of Smell drugs
August 01, 2019
Even a mild concussion can temporarily affect your sense of smell and trigger longer-term anxiety problems, a new study finds.
Family Home, Football Field Most Dangerous Spots for Kids' Head Injuries drugs
July 30, 2019
Falls from beds, uneven floors and playing football are leading causes of nonfatal brain injuries in American kids, new research shows.
Mereo BioPharma Appoints Head of Pharma Development contractpharma
July 17, 2019
Richard Francis brings more than 35 years of experience in biopharmaceutical process development and manufacturing operations.
Avomeen Appoints Head of Elemental Analysis contractpharma
June 18, 2019
Mr. Ferencz will help clients comply with regulations such as USP 232 and USP 233, as well as California Proposition 65.
Head Injuries Tied to Motorized Scooters Are Rising: Study drugs
June 17, 2019
Head Injuries Tied to Motorized Scooters Are Rising.
Mouth Rinse for HPV DNA May Be Biomarker in Head, Neck Cancer drugs
June 11, 2019
Mouth Rinse for HPV DNA May Be Biomarker in Head, Neck Cancer.
Alexion's Soliris almost entirely eliminates relapses in rare neuromyelitis optica spectrum disorder pharmafile
September 27, 2018
Alexion has revealed new Phase 3 findings for Soliris (eculizumab), showing the drug met its primary endpoint in the treatment of anti-aquaporin-4 (AQP4)...